A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's and other forms of dementia. That's the result of a study in which the benefit was so clear, the trial was ...
Detailed price information for Castle Biosciences Inc (CSTL-Q) from The Globe and Mail including charting and trades.
Acadia Pharmaceuticals' two approved drugs, NUPLAZID and DAYBUE are guided to continue their strong growth trajectories. Read ...
SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (ACAD) today announced that the U.S. District Court for the District of Delaware ruled in favor of Acadia regarding its ‘721 formulation patent ...
(Reuters) -Acadia Pharmaceuticals said on Monday that the U.S. Court of Appeals has confirmed the validity of its patent for Nuplazid, its drug for hallucinations and delusions associated with ...
Acadia Pharmaceuticals ACAD shares surged 26.5% on Friday after the company announced that the U.S. District Court in Delaware had ruled in its favor concerning the ‘721 formulation patent for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results